DOW JONES22,679.99+1627.46 7.73%
S&P 5002,663.68+175.03 7.03%
NASDAQ7,913.24+540.16 7.33%

Verrica Pharmaceuticals Q4 EPS $(0.31) Down From $(0.3) YoY

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.31) per share. This is a 3.33 percent decrease over losses of $(0.3) per share from the same period last year.

Benzinga · 03/13/2020 11:11

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.31) per share. This is a 3.33 percent decrease over losses of $(0.3) per share from the same period last year.